AI
RVMD icon

Alphabet Inc’s Revolution Medicines RVMD Stock Holding History

Alphabet Inc’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$552M Sell
2,946,619
-345,906
-11% -$50.5M 0.56% 6
2026
Q1 		$320M Sell
3,292,525
-52,577
-2% -$5.31M 7.97% 4
2025
Q4 		$266M Sell
3,345,102
-788,175
-19% -$51.7M 10.33% 3
2025
Q3 		$193M Hold
4,133,277
– – 8.01% 5
2025
Q2 		$152M Hold
4,133,277
– – 7.12% 5
2025
Q1 		$146M Hold
4,133,277
– – 9.27% 4
2024
Q4 		$181M Sell
4,133,277
-122,898
-3% -$6.2M 10.53% 4
2024
Q3 		$193M Sell
4,256,175
-1,050,900
-20% -$45.8M 10.48% 3
2024
Q2 		$206M Buy
5,307,075
+5,563
+0.1% +$208K 10.43% 3
2024
Q1 		$171M Hold
5,301,512
– – 6.8% 6
2023
Q4 		$152M Buy
+5,301,512
New +$127M 7.05% 6

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Alphabet Inc's RVMD Position: Q2 2026 in Review

Alphabet Inc reduced its Revolution Medicines (RVMD) stake by 11% in Q2 2026, selling an estimated $50.5M and leaving 2,946,619 shares worth $552M. The position accounts for 0.56% of the portfolio, ranked #6.

Alphabet Inc first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Alphabet Inc held 2,946,619 shares of Revolution Medicines worth $552M as of Q2 2026.
  • Alphabet Inc sold 345,906 Revolution Medicines shares in Q2 2026, an estimated $50.5M.
  • Revolution Medicines made up 0.56% of Alphabet Inc's portfolio in Q2 2026, its #6 holding.
  • Alphabet Inc first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Alphabet Inc's 13F filing for Q2 2026, filed 7 Aug 2026.